CARDINAL HEALTH INC Stock Repurchases 2008-2026 | CAH
Beta
What is stock repurchases?
Stock repurchases (buybacks) represent cash spent to buy back the company's own shares from the open market, returning capital to shareholders.
What is CARDINAL HEALTH INC's current stock repurchases?
CARDINAL HEALTH INC (CAH) annual stock repurchases for 2025 was $765.0M, a 2.00% increase from 2024. CARDINAL HEALTH INC stock repurchases for the quarter ending December 31, 2025 was $383.0M.
What was CARDINAL HEALTH INC's stock repurchases in 2024?
CARDINAL HEALTH INC annual stock repurchases for 2024 was $750.0M, a 62.50% decline from 2023.
What was CARDINAL HEALTH INC's stock repurchases in 2023?
CARDINAL HEALTH INC annual stock repurchases for 2023 was $2.00B, a 100.00% increase from 2022.
What is CARDINAL HEALTH INC's 5-year stock repurchases CAGR?
CARDINAL HEALTH INC stock repurchases grew at a compound annual growth rate (CAGR) of 16.93% from FY2020 to FY2025, going from $350.0M to $765.0M over 5 years.
Stock Repurchases History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+16.9%
FY2020
$350.0M
→
FY2025
$765.0M
080910111213141516171819202122232425
5 years selected
Stock Repurchases History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $765.0M | +2.0% | 10-K |
| FY2024 | $750.0M | -62.5% | 10-K |
| FY2023 | $2.00B | +100.0% | 10-K |
| FY2022 | $1.00B | +400.0% | 10-K |
| FY2021 | $200.0M | -42.9% | 10-K |
| FY2020 | $350.0M | -41.7% | 10-K |
| FY2019 | $600.0M | +9.1% | 10-K |
| FY2018 | $550.0M | -8.3% | 10-K |
| FY2017 | $600.0M | -7.8% | 10-K |
| FY2016 | $651.0M | -37.2% | 10-K |
| FY2015 | $1.04B | +53.9% | 10-K |
| FY2014 | $673.0M | +49.6% | 10-K |
| FY2013 | $450.0M | +0.0% | 10-K |
| FY2012 | $450.0M | +66.7% | 10-K |
| FY2011 | $270.0M | +17.4% | 10-K |
| FY2010 | $230.0M | - | 10-K |
| FY2009 | $0 | -100.0% | 10-K |
| FY2008 | $1.18B | - | 10-K |
Company: CARDINAL HEALTH INCTicker: CAHSector: HealthcareIndustry: Wholesale-Drugs, Proprietaries & Druggists' SundriesView company profile →